PMID: 9449277Feb 4, 1998Paper

The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II

Antimicrobial Agents and Chemotherapy
H BrötzH G Sahl

Abstract

The lantibiotic mersacidin exerts its bactericidal action by inhibition of peptidoglycan biosynthesis. It interferes with the membrane-associated transglycosylation reaction; during this step the ultimate monomeric peptidoglycan precursor, undecaprenyl-pyrophosphoryl-MurNAc-(pentapeptide)-GlcNAc (lipid II) is converted into polymeric nascent peptidoglycan. In the present study we demonstrate that the molecular basis of this inhibition is the interaction of mersacidin with lipid II. The adsorption of [14C]mersacidin to growing cells, as well as to isolated membranes capable of in vitro peptidoglycan synthesis, was strictly dependent on the availability of lipid II, and antibiotic inhibitors of lipid II formation strongly interfered with this binding. Direct evidence for the interaction was provided by studies with isolated lipid II. [14C]mersacidin associated tightly with [14C]lipid II micelles; the complex was stable even in the presence of 1% sodium dodecyl sulfate. Furthermore, the addition of isolated lipid II to the culture broth efficiently antagonized the bactericidal activity of mersacidin. In contrast to the glycopeptide antibiotics, complex formation does not involve the C-terminal D-alanyl-D-alanine moiety of the lipi...Continue Reading

References

Mar 1, 1977·Antimicrobial Agents and Chemotherapy·S SommaF Parenti
Jun 1, 1992·The Journal of Antibiotics·S ChatterjeeG Seibert
Sep 1, 1990·The Journal of Antibiotics·A MalabarbaB Cavalleri
Mar 1, 1990·Antimicrobial Agents and Chemotherapy·E A Somner, P E Reynolds
Nov 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P E Reynolds
Dec 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·K J Stone, J L Strominger
May 10, 1974·Annals of the New York Academy of Sciences·D R Storm
Sep 1, 1965·Archives of Biochemistry and Biophysics·G K Best, N N Durham
Sep 26, 1966·Archives of Biochemistry and Biophysics·M DankertP W Robbins
Aug 1, 1968·Journal of Bacteriology·R K Sinha, R C Neuhaus
Jun 15, 1995·European Journal of Biochemistry·H G SahlG Bierbaum
Mar 15, 1995·FEMS Microbiology Letters·G BierbaumH G Sahl
Feb 1, 1996·Antonie van Leeuwenhoek·G N MollA J Driessen
Jul 1, 1996·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·E MolitorH G Sahl

❮ Previous
Next ❯

Citations

Aug 10, 2000·Biopolymers·I F Nes, H Holo
May 12, 2001·FEMS Microbiology Reviews·O McAuliffeC Hill
Oct 31, 2002·Applied and Environmental Microbiology·Daili Jacqueline Aguilar NetzHans-Georg Sahl
Mar 5, 2003·Pharmacological Reviews·Michael R Yeaman, Nannette Y Yount
May 6, 2004·Journal of Bacteriology·Imke WiedemannHans-Georg Sahl
Nov 30, 2005·Molecular Microbiology·Shinya KodaniJoanne M Willey
Apr 15, 2009·Antimicrobial Agents and Chemotherapy·Ilknur SenyürekBirgit Schittek
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·James B HamburgerPatrick J Loll
Aug 11, 2010·FEMS Microbiology Reviews·Hikmate AbriouelAntonio Gálvez
Oct 22, 2011·International Journal of Molecular Sciences·Seong-Cheol ParkKyung-Soo Hahm
Nov 11, 2011·International Journal of Molecular Sciences·Garry LavertyBrendan F Gilmore
Aug 29, 2012·Antimicrobial Agents and Chemotherapy·Michaela WenzelJulia E Bandow
Oct 4, 2013·Immunotherapy·Cesar Enrique Rivas-SantiagoBruno Rivas-Santiago
Jun 1, 2011·Probiotics and Antimicrobial Proteins·Adam Pepperney, Michael L Chikindas
Jan 4, 2017·Biotechnology Letters·Elvis Legala OngeyPeter Neubauer
Dec 23, 2017·Applied and Environmental Microbiology·Mengxin GengLeif Smith
Apr 5, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Awdhesh Kumar MishraKwang-Hyun Baek
Feb 26, 2019·Protein and Peptide Letters·Dan ZhangShufang Liang
Jun 6, 2019·Pharmaceuticals·Boris VishnepolskyMalak Pirtskhalava
Jun 1, 2000·Applied and Environmental Microbiology·K AltenaG Bierbaum
Aug 10, 2000·Biopolymers·A GuderH G Sahl
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Predrag CudicDewey G McCafferty
Mar 21, 2002·Expert Opinion on Therapeutic Targets·David W Green
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Raquel Regina BonelliImke Wiedemann
Jul 4, 2003·Applied and Environmental Microbiology·Christiane SzekatGabriele Bierbaum
Oct 6, 2005·Nature Reviews. Microbiology·Paul D CotterR Paul Ross
Dec 8, 2007·Microbiology and Molecular Biology Reviews : MMBR·Jean van Heijenoort
Jan 19, 2007·European Journal of Organic Chemistry·Radha S Narayan, Michael S Vannieuwenhze
Nov 26, 2010·Critical Reviews in Biotechnology·Ankur GautamRupinder Tewari
Aug 22, 2012·Journal of Applied Microbiology·A A HugoP F Pérez
Jun 29, 2010·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Heike Sträuber, Susann Müller
Aug 4, 2011·PloS One·Anna Maria HerznerGabriele Bierbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.